Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03828734 · ClinicalTrials.gov registry record · NA
Modulation of Cognitive Control Signals in Prefrontal Cortex by Rhythmic Transcranial Magnetic Stimulation
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT03828734 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 58 participants.
The verdict
NCT03828734, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Purpose: In this study, the investigators will provide causal evidence for the role of alpha and theta oscillations in cognitive control. Participants: Participants must be healthy, between the ages of 18 and 35, right handed, able to provide informed consent, willing to comply with all study procedures, and be available for the duration of the study, speak and understand English. Procedures: Alpha and theta brain oscillations will be measured and then entrained using frequency specific rhythmic TMS during a retrospective cued cognitive control task.
Interventions
- DEVICE Theta TMS
- DEVICE Arrhythmic TMS
- DEVICE Alpha TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2019-02-13 |
| Est. Completion | 2019-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03828734
The ClinicalTrials.gov registry entry for NCT03828734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Theta TMS is the first listed.
NCT03828734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03828734 about?
NCT03828734 is a clinical study titled "Modulation of Cognitive Control Signals in Prefrontal Cortex by Rhythmic Transcranial Magnetic Stimulation". Purpose: In this study, the investigators will provide causal evidence for the role of alpha and theta oscillations in cognitive control. Participants: Participants must be healthy, between the ages of 18 and 35, right handed, able to provide informed consent, willing to comply with all study proce...
What is the current status of trial NCT03828734?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2019-02-13. Estimated completion is 2019-11-22.
What interventions are being tested in trial NCT03828734?
The interventions under investigation include: Theta TMS (DEVICE), Arrhythmic TMS (DEVICE), Alpha TMS (DEVICE).
Who is sponsoring clinical trial NCT03828734?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.